Cancer is a destructive disease that causes high levels of morbidity and mortality.
Doxorubicin (DOX) is a highly efficient antineoplastic chemotherapeutic drug, but its use …

One in three people will be diagnosed with cancer during their lifetime. The community of
cancer patients is growing, and several common cancers are becoming increasingly …

Increasing numbers of cancer patients survive and live longer than five years after therapy,
but very often side effects of cancer treatment arise at same time. One of the side effects …

The global incidence of inflammatory bowel disease (IBD), a group of chronic
gastrointestinal disorders, has been rising. The preponderance of evidence demonstrates …

Renal fibrosis is the final common pathway of all chronic kidney diseases progressing to end-
stage renal diseases. Autophagy, a highly conserved lysosomal degradation pathway, plays …

Chemobrain refers to a common sequela experienced by a substantial subset of cancer
patients exposed to chemotherapeutic treatment, a phenomenon that dramatically …

Autophagy is an adaptive catabolic process functioning to promote cell survival in the event
of inappropriate living conditions such as nutrient shortage and to cope with diverse …

Among the potential adverse effects of breast cancer treatment, chemotherapy-related
cognitive impairment (CRCI) has gained increased attention in the past years. In this review …

Doxorubicin (DOX) is a broad‐spectrum antitumor drug while its use is limited due to its
neurobiological side effects associated with depression. We investigated the …

There are various cancer treatments at present, and chemotherapy is one of the main
methods. Chemotherapy‐related cognitive impairment (CRCI), as one of the side effects of …